Munafa Stock Market Course + Intraday & FNO calls 
Autolus Therapeutics (AUTL) Technical (Analysis) Reports Autolus Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Autolus Therapeutics (AUTL)
Technical Analysis Report for USA stock AUTL Autolus Therapeutics. Dated: 20 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock AUTL Autolus Therapeutics then click here. or read Experts views on Autolus Therapeutics or Forecast & share price targets of Autolus Therapeutics
Autolus Therapeutics Opened at 1.45 and Closed at: 1.40, which is -2.86% of previous session's close. It moved within a range of 1.39 and 1.48
The session was a Bearish session with an average volume of 852500, which is 10.83% of previous session's volumes.
A Dead cross was found 2 days back on short term averages
A Dead cross was found 5 days back on mid term averages
Support for tomorrow is 1.35 and resistance for tomorrow is 1.44
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.37, 1.33 resistance for tomorrow's hourly charts is 1.46, 1.51
10 Day SMA for Autolus Therapeutics (AUTL) is 1.54 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Autolus Therapeutics (AUTL) is 1.57 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Autolus Therapeutics (AUTL) is 1.6 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.55 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Autolus Therapeutics is 1.54 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Autolus Therapeutics is at 1.57 and 200 DMA is at 1.54, while 50 DMA and 100 DMA are at 1.6 and 1.55 respectively
Autolus Therapeutics (AUTL) moving average of 20 SMA is at 1.57 and 20 EMA is at 1.54
| Date | Closing Price | 20 SMA | 20 EMA |
| 20 Mon Jul | 1.40 | 1.57 | 1.54 |
| 17 Fri Jul | 1.44 | 1.58 | 1.55 |
| 16 Thu Jul | 1.46 | 1.58 | 1.56 |
| 15 Wed Jul | 1.51 | 1.58 | 1.57 |
| 14 Tue Jul | 1.45 | 1.58 | 1.58 |
| 13 Mon Jul | 1.48 | 1.59 | 1.59 |
Autolus Therapeutics (AUTL) moving average of 50 SMA is at 1.6 and 50 EMA is at 1.56
| Date | Closing Price | 50 SMA | 50 EMA |
| 20 Mon Jul | 1.40 | 1.6 | 1.56 |
| 17 Fri Jul | 1.44 | 1.61 | 1.57 |
| 16 Thu Jul | 1.46 | 1.61 | 1.58 |
| 15 Wed Jul | 1.51 | 1.62 | 1.58 |
| 14 Tue Jul | 1.45 | 1.62 | 1.58 |
| 13 Mon Jul | 1.48 | 1.62 | 1.59 |
Autolus Therapeutics (AUTL) moving average of 100 SMA is at 1.55 and 100 EMA is at 1.59
| Date | Closing Price | 100 SMA | 100 EMA |
| 20 Mon Jul | 1.40 | 1.55 | 1.59 |
| 17 Fri Jul | 1.44 | 1.56 | 1.59 |
| 16 Thu Jul | 1.46 | 1.56 | 1.59 |
| 15 Wed Jul | 1.51 | 1.56 | 1.59 |
| 14 Tue Jul | 1.45 | 1.56 | 1.59 |
| 13 Mon Jul | 1.48 | 1.56 | 1.59 |
Autolus Therapeutics (AUTL) moving average of 200 SMA is at 1.54 and 200 EMA is at 1.77
| Date | Closing Price | 200 SMA | 200 EMA |
| 20 Mon Jul | 1.40 | 1.54 | 1.77 |
| 17 Fri Jul | 1.44 | 1.54 | 1.77 |
| 16 Thu Jul | 1.46 | 1.55 | 1.77 |
| 15 Wed Jul | 1.51 | 1.55 | 1.77 |
| 14 Tue Jul | 1.45 | 1.55 | 1.77 |
| 13 Mon Jul | 1.48 | 1.55 | 1.77 |
Teleflex Incorporated has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Teleflex Incorporated, about 16.2% more returns!
Novo Nordisk has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Novo Nordisk, about 14.19% more returns!
Merck Company has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Merck Company, about 13.77% more returns!
Medtronic Plc has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Medtronic Plc, about 11.12% more returns!
Verastem Inc has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Verastem Inc, about 41.33% more returns!
Urogen Pharma has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Urogen Pharma, about 23.56% more returns!
Autolus Therapeutics has performed better than Spero Therapeutics in short term. Holding Autolus Therapeutics could be a better choice for now!
Jazz Pharmaceuticals has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Jazz Pharmaceuticals, about 13.81% more returns!
Iovance Biotherapeutics has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Iovance Biotherapeutics, about 30.18% more returns!
Idexx Laboratories has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Idexx Laboratories, about 9.35% more returns!
Enanta Pharmaceuticals has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Enanta Pharmaceuticals, about 4.47% more returns!
Cue Biopharma has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Cue Biopharma, about 6.76% more returns!
Autolus Therapeutics has performed better than Cytosorbents Corporation in short term. Holding Autolus Therapeutics could be a better choice for now!
Crinetics Pharmaceuticals has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Crinetics Pharmaceuticals, about 143.09% more returns!
Cumberland Pharmaceuticals has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Cumberland Pharmaceuticals, about 37.1% more returns!
Autolus Therapeutics has performed better than Axsome Therapeutics in short term. Holding Autolus Therapeutics could be a better choice for now!
Alphatec Holdings has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Alphatec Holdings, about 2.77% more returns!
Anixa Biosciences has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Anixa Biosciences, about 30.23% more returns!
Autolus Therapeutics Technical analysis of indicators
Price action analysis of Autolus Therapeutics (AUTL) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Autolus Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Autolus Therapeutics in short term and the sell signal is strong.
Autolus Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Autolus Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Autolus Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.53 and Autolus Therapeutics AUTL stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Autolus Therapeutics AUTL stock. Volume based technical analysis of Autolus Therapeutics AUTL stock is negative.
Autolus Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock AUTL Autolus Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AUTL Experts View which covers a lot of information including buying and selling signals
AUTL future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Autolus Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Autolus Therapeutics (AUTL) Technical (Analysis) Reports Autolus Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
